Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 230 member I (FAM230I) is a gene encoding a long intergenic non-coding RNA classified as LINC01658. lincRNAs like FAM230I are autonomously transcribed RNA molecules over 200 nucleotides long that do not overlap with protein-coding genes[1][2][4][6]. These RNAs function mainly in the regulation of gene expression, including chromatin architecture remodeling, transcriptional regulation, and genome stability. Although thousands of lincRNAs have been annotated, only a minority have a well-defined role, and FAM230I currently lacks specific functional or disease-related annotation. lincRNAs are essential for fine-tuning gene expression in a tissue- and context-dependent manner but are not generally pharmacological targets[2][4][6]. FAM230I is a non-coding RNA gene, not a protein-coding gene, receptor, or classical therapeutic target, and is most accurately classified under the long intergenic non-coding RNA family[1][2][4][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 230 member I (FAM230I).